SCHEMBL7690653

SCHEMBL7690653

CS(=O)(=O)N(c1ccc(C(=O)O)c(Cl)c1)S(C)(=O)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
TSHR P16473 1/20 0.50
CASP1 P29466 1/20 0.50
LMNA P02545 1/20 0.46
MYC P01106 1/20 0.44
NR4A1 P22736 1/20 0.44
ALDH1A1 P00352 3/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA3 P07451 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
CA5A P35218 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA13 Q8N1Q1 1/20 0.40
CISD1 Q9NZ45 1/20 0.40
CA14 Q9ULX7 1/20 0.40
CA5B Q9Y2D0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13602153 0.87 SMN1; SMN2 (0.42) SMN1; SMN2LMNAALDH1A1RAB9AFLT1
SCHEMBL1018173 0.85 SMN1; SMN2 (0.49) SMN1; SMN2TSHRCASP1LMNAMYC
SCHEMBL7689229 0.83 RAB9A (0.46) SMN1; SMN2TSHRLMNAALDH1A1CA12
SCHEMBL13689959 0.82 SMN1; SMN2 (0.38) SMN1; SMN2LMNAALDH1A1RAB9AFLT1
SCHEMBL17142873 0.79 SMN1; SMN2 (0.57) SMN1; SMN2TSHRCASP1MYCNR4A1
SCHEMBL7142490 0.79 GABRP (0.38) SMN1; SMN2TSHRLMNAALDH1A1FLT1
SCHEMBL1015441 0.78 MCL1 (0.52) SMN1; SMN2ALDH1A1RAB9A
SCHEMBL8634139 0.78 KMT2A (0.41) TSHRLMNAMYCALDH1A1KMT2A
SCHEMBL2964176 0.77 SMN1; SMN2 (0.42) SMN1; SMN2LMNAALDH1A1CA12CA1
SCHEMBL1018546 0.76 LMNA (0.51) SMN1; SMN2TSHRCASP1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides MUSIL TIBOR (GB) 2002-04-18 US disclosed
US-6323155-B1 EXCELLENT LEVEL OF HERBICIDAL ACTIVITY TOGETHER WITH CROP TOLERANCE RHONE-POULENC AGRICULTURE LIMITED (GB) 2001-11-27 US disclosed
EP-0811611-B1 2-cyano-1-sulfonamidophenyl-1,3-dione derivatives and their use as herbicides RHONE POULENC AGRICULTURE (GB) 2000-01-26 EP disclosed
US-5804532-A REACTING A BENZOYL ISOXAZOLE WITH A BASE RHONE-POULENC AGRICULTURE LIMITED (GB) 1998-09-08 US disclosed
EP-0674629-B1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE POULENC AGRICULTURE (GB) 1998-07-08 EP disclosed
EP-0811611-A1 2-cyano-1-sulfonamidophenyl-1,3-dione derivatives and their use as herbicides RHONE-POULENC AGRICULTURE LTD. (GB) 1997-12-10 EP disclosed
EP-0674629-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1995-10-04 EP disclosed
EP-0625505-A2 2-Cyano-1,3-dione derivatives and their use as herbicides RHONE POULENC AGRICULTURE LTD. (GB) 1994-11-23 EP disclosed
WO-1994014782-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1994-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides CBR3, CBR1, GLRA3 SMN1; SMN2 3433/4885TSHR 174/4885CASP1 2185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.